- Report
- October 2024
- 196 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
- Report
- February 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- February 2024
- 185 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- March 2025
- 75 Pages
Global
From €3500EUR$4,120USD£3,106GBP
Betaxolol is a cardioselective beta-blocker used to treat hypertension, angina, and other cardiovascular conditions. It works by blocking the action of certain natural chemicals in the body, such as epinephrine, that affect the heart and blood vessels. Betaxolol is available in both oral and intravenous forms. It is generally well tolerated, with few side effects.
Betaxolol is used to treat a variety of cardiovascular conditions, including hypertension, angina, and arrhythmias. It is also used to prevent heart attacks and strokes. Betaxolol is often prescribed in combination with other medications, such as diuretics, ACE inhibitors, and calcium channel blockers.
Betaxolol is available in generic and brand-name formulations. Some of the major companies in the market include Pfizer, Merck, Novartis, and GlaxoSmithKline. Show Less Read more